Northern California Retina Vitreous Associates
6 clinical trials · Sponsor
◉ Watch Northern California Retina Vitreous Associates
| Record | Firm | Date |
|---|---|---|
| The Endurance 1 Trial (NCT02297204) | Northern California Retina Vitreous Associates | 2014-11-01 |
| Intravitreal Gas for Vitreomacular Adhesion (NCT02001701) | Northern California Retina Vitreous Associates | 2013-11-01 |
| Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept. (NCT01972763) | Northern California Retina Vitreous Associates | 2013-10-01 |
| NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions (NCT01870427) | Northern California Retina Vitreous Associates | 2013-06-01 |
| TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema (NCT01870440) | Northern California Retina Vitreous Associates | 2013-05-01 |
| Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery (NCT01284478) | Northern California Retina Vitreous Associates | 2011-01-01 |
Track Northern California Retina Vitreous Associates automatically
Every clearance here is in the API, with alerts when new ones post.